R-(-)-hydrochlorure de déprenyl, poudre, >= 98% ( HPLC)

Code: M003-250MG D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Selective MAO-B inhibitor; anti-Parkinsonian agent.

Features and Benefits

This compound is featured on the Dopamine and N...


 En savoir plus

Votre prix
$109.31 250MG
DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Selective MAO-B inhibitor; anti-Parkinsonian agent.

Features and Benefits

This compound is featured on the Dopamine and Norepinephrine Metabolism and Histamine Synthesis and Metabolism pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

1 g in poly bottle

250 mg in poly bottle

assay≥98% (HPLC)
colorwhite
formpowder
Gene Informationhuman ... MAOB(4129)
InChI keyIYETZZCWLLUHIJ-UTONKHPSSA-N
InChI1S/C13H17N.ClH/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13;/h1,5-9,12H,10-11H2,2-3H3;1H/t12-;/m1./s1
mp141-142 °C
optical activity[α]25/D −10.8°, c = 6.48 in H2O(lit.)
originatorSanofi Aventis
Quality Level100
SMILES stringCl[H].C[C@H](Cc1ccccc1)N(C)CC#C
solubilityH2O: >10 mg/mL
Cas Number14611-52-0
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN
GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.